© Reuters. Thermo Fisher Scientific earnings beat by $0.18, revenue topped estimates
Investing.com – Thermo Fisher Scientific (NYSE: TMO) reported fourth quarter EPS of $5.40, $0.18 better than the analyst estimate of $5.22. Revenue for the quarter came in at $11.45B versus the consensus estimate of $10.46B.
Guidance
Thermo Fisher Scientific sees FY 2023 EPS of versus the analyst consensus of $23.26.
Thermo Fisher Scientific sees FY 2023 revenue of $45.30B
Thermo Fisher Scientific’s stock price closed at $570.33. It is up 15.09% in the last 3 months and down -5.59% in the last 12 months.
Thermo Fisher Scientific saw 5 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Thermo Fisher Scientific’s stock price’s past reactions to earnings here.
According to InvestingPro, Thermo Fisher Scientific’s Financial Health score is “great performance“.
Check out Thermo Fisher Scientific’s , and Thermo Fisher Scientific’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment